153 related articles for article (PubMed ID: 17409901)
1. Decreased immunoreactivity of CD99 is an independent predictor of regional lymph node metastases in pulmonary carcinoid tumors.
Pelosi G; Leon ME; Veronesi G; Spaggiari L; Pasini F; Viale G
J Thorac Oncol; 2006 Jun; 1(5):468-77. PubMed ID: 17409901
[TBL] [Abstract][Full Text] [Related]
2. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids.
Pelosi G; Pasini F; Fraggetta F; Pastorino U; Iannucci A; Maisonneuve P; Arrigoni G; De Manzoni G; Bresaola E; Viale G
Lung Cancer; 2003 Nov; 42(2):203-13. PubMed ID: 14568688
[TBL] [Abstract][Full Text] [Related]
3. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
4. CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours.
Pelosi G; Fraggetta F; Sonzogni A; Fazio N; Cavallon A; Viale G
Virchows Arch; 2000 Sep; 437(3):270-4. PubMed ID: 11037347
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
[TBL] [Abstract][Full Text] [Related]
6. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
7. CK19 and CD99 immunoexpression profile in goblet cell (mucin-producing neuroendocrine tumors) and classical carcinoids of the vermiform appendix.
Alsaad KO; Serra S; Perren A; Hsieh E; Chetty R
Int J Surg Pathol; 2007 Jul; 15(3):252-7. PubMed ID: 17652531
[TBL] [Abstract][Full Text] [Related]
8. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
[TBL] [Abstract][Full Text] [Related]
9. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.
Thomas CF; Tazelaar HD; Jett JR
Chest; 2001 Apr; 119(4):1143-50. PubMed ID: 11296182
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
11. CD99 expression in Merkel cell carcinoma: a case series with an unusual paranuclear dot-like staining pattern.
Rajagopalan A; Browning D; Salama S
J Cutan Pathol; 2013 Jan; 40(1):19-24. PubMed ID: 23145531
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers help characterize neuroendocrine lung tumors.
Rusch VW; Klimstra DS; Venkatraman ES
Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
[TBL] [Abstract][Full Text] [Related]
14. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
Long KB; Srivastava A; Hirsch MS; Hornick JL
Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
[TBL] [Abstract][Full Text] [Related]
15. CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas.
Pelosi G; Masullo M; Leon ME; Veronesi G; Spaggiari L; Pasini F; Sonzogni A; Iannucci A; Bresaola E; Viale G
Virchows Arch; 2004 Nov; 445(5):449-55. PubMed ID: 15375659
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs).
Goto A; Niki T; Terado Y; Fukushima J; Fukayama M
Histopathology; 2004 Oct; 45(4):384-92. PubMed ID: 15469477
[TBL] [Abstract][Full Text] [Related]
17. [Typical and atypical pulmonary carcinoids--pathologic and clinical analysis of 77 cases].
Słodkowska J; Langfort R; Rudziński P; Kupis W
Pneumonol Alergol Pol; 1998; 66(5-6):297-303. PubMed ID: 9857650
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors.
Lee HW; Lee EH; Ha SY; Lee CH; Chang HK; Chang S; Kwon KY; Hwang IS; Roh MS; Seo JW
Pathol Int; 2012 Sep; 62(9):583-91. PubMed ID: 22924844
[TBL] [Abstract][Full Text] [Related]
19. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.
Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF
Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases.
Kneuertz PJ; Kamel MK; Stiles BM; Lee BE; Rahouma M; Harrison SW; Altorki NK; Port JL
Ann Thorac Surg; 2018 Oct; 106(4):981-988. PubMed ID: 29908980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
